Delaware Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 3 (100% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 619
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 85.47%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 147
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 87.12%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 10.82% 11.56%
White, Hispanic/Latino Patients 20.84% 29.25%
Black/African American, Non-Hispanic/Latino Patients 32.63% 38.10%
Black/African American, Hispanic/Latino Patients 1.29% 0.68%
Asian Patients3 1.13% 0.00%
American Indian/Alaska Native Patients3 0.65% 0.68%
Native Hawaiian/Other Pacific Islander Patients3 0.32% 0.00%
Patients with More Than One Race3 1.29% 2.04%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 5.49% 7.48%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.94% 2.72%
Unreported/Refused to Report Race and Ethnicity 23.59% 7.48%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 447
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 78.52%
COVID-19 Immunization Series Completed 313
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 77.82%
COVID-19 Immunization Series Additional 830
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 71.39%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 20.13% 19.49% 24.10%
White, Hispanic/Latino Patients 46.09% 37.38% 39.64%
Black/African American, Non-Hispanic/Latino Patients 1.79% 5.11% 1.57%
Black/African American, Hispanic/Latino Patients 1.79% 0.96% 2.41%
Asian Patients3 0.00% 0.00% 0.12%
American Indian/Alaska Native Patients3 3.58% 3.83% 2.29%
Native Hawaiian/Other Pacific Islander Patients3 1.79% 0.00% 0.00%
Patients with More Than One Race3 10.74% 5.43% 8.31%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 7.83% 15.65% 5.78%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.67% 9.27% 1.20%
Unreported/Refused to Report Race and Ethnicity 5.59% 2.88% 14.58%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 0.00%
1 to 24 Hours 33.33%
More Than 24 Hours 66.67%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 66.67%
Vaccine confidence 66.67%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 0.00%
None 0.00%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 33.33%
Average Percent of Health Center Visits Conducted Virtually 40.00%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 66.67%
Number of Mobile Van Sites 0
Number of Pop-up Clinics 3
Number of School-Based Vaccination Sites 0
Number of Family Vaccination Clinics 10

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 66.67%
None 33.33%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 33.33%
Patient awareness/education 33.33%
Staffing capacity 33.33%
Therapy administration/onsite logistics 33.33%
Other 0.00%
None 66.67%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 1
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 78

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 100.00%
Provide to General Public Who Came to the Health Center 100.00%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 0.00%
Provide at Other Community Events 0.00%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 0.00%
Other 0.00%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 0
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 -

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients -
White, Hispanic/Latino Patients -
Black/African American, Non-Hispanic/Latino Patients -
Black/African American, Hispanic/Latino Patients -
Asian Patients3 -
American Indian/Alaska Native Patients3 -
Native Hawaiian/Other Pacific Islander Patients3 -
Patients with More Than One Race3 -
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) -
Unreported/Refused to Report Race and Ethnicity -

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers -
Patients Experiencing Homelessness -
Patients Who Are Residents of Public Housing -
Patients with Limited English Proficiency -
Children Under 18 Years of Age -

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022